Sodium 3-[[[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-amino]ca

Details Sodium 3-[[[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-amino]ca Sodium 3-[[[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-amino]ca

1978-05-22

1980-03-18

Berch, Mark L.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

Attached to antibody or antibody fragment or immunoglobulin;...

544350, 546 5, 546 12, 546278, 546112, C07D40112, A61K 4300

Patent

active

041939794

ABSTRACT:
Sodium 3-[[[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-amino]carbonyl]-2-pyridin ecarboxylic acid and related compounds which are labeled with radioactive technetium-99m are described as well as their preparations. These novel complexes are useful by reason of their utility as radiopharmaceutical imaging agents. Particularly, these complexes are useful as gallbladder and liver imaging agents.

REFERENCES:
patent: 3642836 (1972-02-01), Cusic et al.
patent: 3770763 (1973-11-01), Cusic et al.
patent: 4010251 (1977-03-01), Green
Vasa et al., Chem. Abs. 70, 37896t (1968).

Affiliated with

Also associated with

Rating

Sodium 3-[[[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-amino]ca does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sodium 3-[[[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-amino]ca, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sodium 3-[[[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]-amino]ca will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1124094